ACTRN12618001640291招募中未知
Additive diagnostic value of prostate specific membrane antigen (PSMA) positron emission tomography (PET) to multiparametric magnetic resonance imaging (mpMRI) in the diagnostic setting: Ability to reduce unnecessary prostate biopsies in men being investigated for prostate cancer.
St Vincent's Hospital0 个研究点目标入组 200 人开始时间: 2018年10月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •Male, aged 18 years or over
- •Suspicion or prostate cancer with either an abnormal DRE OR PSA greater than age specific reference range on two or more occasions
- •No previously diagnosed prostate cancer
- •No previous prostate biopsies
- •Has undergone an mpMRI within the last 6 months, or scheduled to undergo an mpMRI prior to biopsy
- •Ability to give written informed consent, participate in and comply with the study
排除标准
- •Previous diagnosis of PCa
- •Previous prostate biopsies
- •Inability/ incapacity to provide own consent
- •PSA >20ng/ml
- •greater than or equal to cT3 on DRE
- •Contraindication to MRI, including but not restricted to:
- •oPacemaker or other electronic implant
- •oAllergy or contraindiation to MRI contrast, e.g. renal failure (eGFR <30mL/min)
- •oShrapnel, tattoos, non-removable body piercings (relative contraindication)
研究者
相似试验
招募中
2 期
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pre-operative Lymph Node Assessment in Intermediate and High-risk Nonmetastasic Prostate CancerProstate Cancer2024-516319-25-00Centre Hospitalier Regional Et Universitaire De Brest159
终止
不适用
The use of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans and Magnetic Resonance Imaging (MRI) to better guide high dose radiotherapy for men with high-risk prostate cancer as a means to improve clinical and quality of life outcomes.High risk prostate cancerACTRN12617000816358The Garvan Institute of Medical Research20
招募中
Unknown
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
招募中
不适用
The added value of MRI for detection of prostate cancer: validation with MR guided biopsies, fusion of MRI and transrectal ultrasound guided biopsies and TRUS guided biopsies.prostate carcinoma10038594prostate cancerNL-OMON32545niversitair Medisch Centrum Sint Radboud60
Unknown
不适用
The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate LesionsProstate CancerNCT03174054Assuta Medical Center70